BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 37958893)

  • 21. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total flavonoids of Selaginella tamariscina (P.Beauv.) Spring ameliorates doxorubicin-induced cardiotoxicity by modulating mitochondrial dysfunction and endoplasmic reticulum stress via activating MFN2/PERK.
    Gao L; Yuan P; Wei Y; Fu Y; Hou Y; Li P; Chen Y; Ruan Y; Zhou N; Zheng X; Feng W
    Phytomedicine; 2022 Jun; 100():154065. PubMed ID: 35358932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
    Wang Y; Liao J; Luo Y; Li M; Su X; Yu B; Teng J; Wang H; Lv X
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioredoxin Reductase 2 Synergizes with Cytochrome c, Somatic to Alleviate Doxorubicin-Induced Oxidative Stress in Cardiomyocytes and Mouse Myocardium.
    Li C; Lai H; Cai X; Liu Y; Hong L; Huang X; Shao L
    Int Heart J; 2023 Mar; 64(1):60-70. PubMed ID: 36725079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 7,8,3'-Trihydroxyflavone prevents doxorubicin-induced cardiotoxicity and mitochondrial dysfunction via activating Akt signaling pathway in H9c2 cells.
    Zhao J; Yu HQ; Ge FQ; Zhang MR; Song YC; Guo DD; Li QH; Zhu H; Hang PZ
    Cell Signal; 2023 Dec; 112():110924. PubMed ID: 37838311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.
    Chen CT; Wang ZH; Hsu CC; Lin HH; Chen JH
    Nutrients; 2015 Jun; 7(6):4938-54. PubMed ID: 26091236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sophocarpine alleviates doxorubicin-induced heart injury by suppressing oxidative stress and apoptosis.
    Zhang HJ; Fu Y; Zhang H; Lai ZQ; Dong YF
    Sci Rep; 2024 Jan; 14(1):428. PubMed ID: 38172265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
    Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
    Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury.
    Cai W; Teng T; Wang X; Li B; Gu X; Zhou Y
    J Toxicol Sci; 2023; 48(8):469-479. PubMed ID: 37532580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity.
    Naderi Y; Khosraviani S; Nasiri S; Hajiaghaei F; Aali E; Jamialahmadi T; Banach M; Sahebkar A
    Biomed Pharmacother; 2023 Feb; 158():114055. PubMed ID: 36495663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise during pregnancy decreases doxorubicin-induced cardiotoxic effects on neonatal hearts.
    Brito VB; Nascimento LV; Nunes RB; Moura DJ; Lago PD; Saffi J
    Toxicology; 2016 Aug; 368-369():46-57. PubMed ID: 27565713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
    Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
    Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials.
    Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM
    Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats.
    Miyoshi T; Nakamura K; Amioka N; Hatipoglu OF; Yonezawa T; Saito Y; Yoshida M; Akagi S; Ito H
    Sci Rep; 2022 Mar; 12(1):4930. PubMed ID: 35322164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
    Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
    J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
    Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
    Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
    Shi R; Huang CC; Aronstam RS; Ercal N; Martin A; Huang YW
    BMC Pharmacol; 2009 Apr; 9():7. PubMed ID: 19368719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
    Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
    Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
    Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
    Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.